APA (7th ed.) Citation

Patachi, B., Jensen, K. H., Gothelf, A., Bernsdorf, M., Friborg, J., & Kristensen, C. A. Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer – real-world single-centre data. Medical Journals Sweden.

Chicago Style (17th ed.) Citation

Patachi, Bogdana, Kristian H. Jensen, Anita Gothelf, Mogens Bernsdorf, Jeppe Friborg, and Claus A. Kristensen. Pembrolizumab as First-line Treatment for Recurrent and Metastatic Head and Neck Cancer – Real-world Single-centre Data. Medical Journals Sweden.

MLA (9th ed.) Citation

Patachi, Bogdana, et al. Pembrolizumab as First-line Treatment for Recurrent and Metastatic Head and Neck Cancer – Real-world Single-centre Data. Medical Journals Sweden.